losartan has been researched along with adenosine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cano, C; Malik, KU; Slavik, KJ | 1 |
| Jackson, EK; Munger, KA | 1 |
| Barrett, RJ; Droppleman, DA | 1 |
| Cox, BF; Kitzen, JM; Perrone, MH; Smits, GJ | 1 |
| Barbant, SD; Chatterjee, K; Gupta, M; MacGregor, JS; Redberg, R; Sudhir, K; Yock, PG | 1 |
| Abramson, BL; Ando, Si; Brooks, SC; Floras, JS; Rongen, GA | 1 |
| Clanachan, AS; Dyck, JR; Ford, WR; Jugdutt, BI; Kumar, D; Lopaschuk, GD; Xu, Y | 1 |
| Hein, TW; Kuo, L; Wang, W; Zhang, C | 1 |
| Chen, H; McClure, JM; O'Leary, DS; Rossi, NF; Scislo, TJ | 1 |
1 review(s) available for losartan and adenosine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for losartan and adenosine
| Article | Year |
|---|---|
Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine.
Topics: Adenosine; Adrenergic beta-Antagonists; Adult; Angiotensin Receptor Antagonists; Cross-Over Studies; Double-Blind Method; Hemodynamics; Humans; Losartan; Male; Nitroprusside; Norepinephrine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sympathetic Nervous System | 1998 |
12 other study(ies) available for losartan and adenosine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Loss of adenosine-induced negative inotropic effect in hyperexcited rabbit hearts: relationship to PKC.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Behavior, Animal; Biphenyl Compounds; Blood Pressure; Depression, Chemical; Enzyme Activation; Heart Rate; Imidazoles; In Vitro Techniques; Losartan; Male; Myocardial Contraction; Naphthalenes; Norepinephrine; Perfusion; Phentolamine; Phorbol 12,13-Dibutyrate; Polycyclic Compounds; Propranolol; Protein Kinase C; Rabbits; Tetradecanoylphorbol Acetate; Tetrazoles | 1995 |
Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.
Topics: Adenosine; Analysis of Variance; Angiotensin II; Animals; Arterioles; Biphenyl Compounds; Blood Pressure; Capillaries; Glomerular Filtration Rate; Hematocrit; Hemodynamics; Imidazoles; Kidney Glomerulus; Losartan; Models, Cardiovascular; Muscle, Smooth, Vascular; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Reference Values; Regional Blood Flow; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Vascular Resistance; Xanthines | 1994 |
Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Topics: Adenine; Adenosine; Angiotensin II; Animals; Arginine; Arginine Vasopressin; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Regional Blood Flow; Renal Circulation; Serotonin; Tetrazoles; Thromboxane A2; Vascular Resistance; Vasoconstriction | 1993 |
Angiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilation.
Topics: Adenosine; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Nifedipine; Nitroglycerin; Rats; Rats, Sprague-Dawley; Tetrazoles; Vascular Resistance; Vasodilation | 1993 |
Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies.
Topics: Adenosine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Blood Flow Velocity; Coronary Circulation; Coronary Vessels; Dogs; Enalaprilat; Female; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Rest; Tetrazoles; Ultrasonography; Vasodilation | 1993 |
AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts.
Topics: Adenosine; Adrenergic alpha-Agonists; Anaerobiosis; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Cyclic GMP; Enalaprilat; Gene Expression Regulation; Heart; Hemodynamics; In Vitro Techniques; Losartan; Mitogen-Activated Protein Kinases; Myocardial Reperfusion; Myocardial Reperfusion Injury; p38 Mitogen-Activated Protein Kinases; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Time Factors; Ventricular Function, Left | 2002 |
Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function.
Topics: Adenosine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Free Radical Scavengers; Imidazoles; In Vitro Techniques; Losartan; Microcirculation; NADPH Oxidases; Nitric Oxide; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Superoxides; Swine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Vasomotor System | 2003 |
Vasopressin is a major vasoconstrictor involved in hindlimb vascular responses to stimulation of adenosine A(1) receptors in the nucleus of the solitary tract.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adrenalectomy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Baroreflex; Blood Pressure; Heart Rate; Hindlimb; Iliac Artery; Losartan; Male; Microinjections; Muscle, Skeletal; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Angiotensin, Type 1; Receptors, Vasopressin; Regional Blood Flow; Solitary Nucleus; Sympathectomy; Time Factors; Vasoconstriction; Vasopressins | 2009 |